Selective localization of interleukin-1 receptor antagonist in eutopic endometrium and endometriotic implants.
OBJECTIVE
To determine whether interleukin-1 receptor antagonist (IL-1ra) expression was concordant in eutopic endometrium and endometriotic implants.


METHODS
Paired samples of endometrium and endometriotic implants from eight patients with endometriosis were used.


METHODS
Interleukin-1 receptor antagonist was demonstrated immunohistochemically on frozen sections of eutopic and ectopic endometria. A sandwich technique with polyclonal rabbit anti-IL-1ra antibody and an avidin-biotin reagent (Vector Laboratories, Inc. Burlingame, CA) was used.


RESULTS
Seven of eight (88%) eutopic endometrial sections revealed staining of glandular epithelium with complete absence of any staining of the stromal compartment. In the counterpart sections of endometriosis, the glandular as well as the stromal compartments were negative for IL-1ra in all patients.


CONCLUSIONS
These data suggest a differential production of the IL-1ra in eutopic endometrium and endometriotic implants. The potential clinical implications of this finding are discussed.
Sahakian
V
V
Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill 27599.
Anners
J
J
Haskill
S
S
Halme
J
J
D000328:Adult; D001706:Biopsy; D004715:Endometriosis / Q000378:metabolism* / Q000473:pathology; D004717:Endometrium / Q000378:metabolism* / Q000473:pathology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors*; D013194:Staining and Labeling; D014018:Tissue Distribution
D017472:Receptors, Interleukin-1